| 000 | 01519 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250511193026.0 | ||
| 264 | 0 | _c19920605 | |
| 008 | 199206s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJackson, C V | |
| 245 | 0 | 0 |
_aPharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cMay 1992 |
||
| 300 |
_a546-52 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
| 650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
| 650 | 0 | 4 |
_aCoronary Thrombosis _xprevention & control |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aHeparin _xtherapeutic use |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aModels, Cardiovascular |
| 650 | 0 | 4 |
_aOligopeptides _xblood |
| 650 | 0 | 4 | _aPartial Thromboplastin Time |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aProthrombin Time |
| 700 | 1 | _aCrowe, V G | |
| 700 | 1 | _aFrank, J D | |
| 700 | 1 | _aWilson, H C | |
| 700 | 1 | _aCoffman, W J | |
| 700 | 1 | _aUtterback, B G | |
| 700 | 1 | _aJakubowski, J A | |
| 700 | 1 | _aSmith, G F | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 261 _gno. 2 _gp. 546-52 |
|
| 999 |
_c1584854 _d1584854 |
||